Prediction of Schizophrenia Diagnosis by Integration of Genetically Correlated Conditions and Traits
Tóm tắt
Schizophrenia is genetically heterogeneous and comorbid with many conditions. In this study, we explored polygenic scores (PGSs) from genetically related conditions and traits to predict schizophrenia diagnosis using both logistic regression and deep neural network (DNN) models. We used the combined Molecular Genetics of Schizophrenia and Swedish Schizophrenia Case Control Study (MGS + SSCCS) data for training and testing the models, and used the Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE) data as independent validation. We screened 28 conditions and traits comorbid with schizophrenia to identify traits as potential predictors and used LASSO regression to select predictors for model construction. We investigated how PGS calculation influenced model performance. We found that the inclusion of comorbid traits improved model performance and PGSs calculated from two traits were more generalizable in independent validation. With a DNN model using 19 PGS predictors, we accomplished a prediction accuracy of 0.813 and an AUC of 0.905 in the MGS + SSCCS data. When this model was validated with the CATIE data, it achieved an accuracy of 0.721 and AUC of 0.747. Our results indicate that PGSs alone may not be sufficient to predict schizophrenia accurately and the inclusion of behavioral and clinical data may be necessary for more accurate prediction model.
Tài liệu tham khảo
Abadi M, Agarwal A, Barham P, et al (2016) TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems. ArXiv160304467 Cs
Algamal ZY, Alhamzawi R, Mohammad Ali HT (2018) Gene selection for microarray gene expression classification using Bayesian Lasso quantile regression. Comput Biol Med 97:145–152. https://doi.org/10.1016/j.compbiomed.2018.04.018
Bergen SE, O’Dushlaine CT, Ripke S et al (2012) Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 17:880–886. https://doi.org/10.1038/mp.2012.73
Bernardini F, Attademo L, Cleary SD et al (2017) Risk prediction models in psychiatry: toward a new frontier for the prevention of mental illnesses. J Clin Psychiatry 78:572–583. https://doi.org/10.4088/JCP.15r10003
Buckley PF, Miller BJ, Lehrer DS, Castle DJ (2009) Psychiatric comorbidities and schizophrenia. Schizophr Bull 35:383–402. https://doi.org/10.1093/schbul/sbn135
Bulik-Sullivan B, Finucane HK, Anttila V et al (2015) An atlas of genetic correlations across human diseases and traits. Nat Genet 47:1236–1241. https://doi.org/10.1038/ng.3406
Euesden J, Lewis CM, O’Reilly PF (2015) PRSice: polygenic risk score software. Bioinforma Oxf Engl 31:1466–1468. https://doi.org/10.1093/bioinformatics/btu848
Ferentinos P, Dikeos D (2012) Genetic correlates of medical comorbidity associated with schizophrenia and treatment with antipsychotics. Curr Opin Psychiatry 25:381–390. https://doi.org/10.1097/YCO.0b013e3283568537
Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33:1–22
Frost HR, Amos CI (2017) Gene set selection via LASSO penalized regression (SLPR). Nucleic Acids Res 45:e114–e114. https://doi.org/10.1093/nar/gkx291
Howie B, Fuchsberger C, Stephens M et al (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44:955–959. https://doi.org/10.1038/ng.2354
International Schizophrenia Consortium, Purcell SM, Wray NR et al (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748–752. https://doi.org/10.1038/nature08185
Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP (1996) Medical comorbidity in schizophrenia. Schizophr Bull 22:413–430
Jones HJ, Stergiakouli E, Tansey KE et al (2016) Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population. JAMA Psychiatry 73:221–228. https://doi.org/10.1001/jamapsychiatry.2015.3058
Li C, Yang C, Gelernter J, Zhao H (2014) Improving genetic risk prediction by leveraging pleiotropy. Hum Genet 133:639–650. https://doi.org/10.1007/s00439-013-1401-5
Ruderfer DM, Fanous AH, Ripke S et al (2014) Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry 19:1017–1024. https://doi.org/10.1038/mp.2013.138
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421–427. https://doi.org/10.1038/nature13595
Shafee R, Nanda P, Padmanabhan JL et al (2018) Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls. Transl Psychiatry 8:78. https://doi.org/10.1038/s41398-018-0124-8
Shi J, Levinson DF, Duan J et al (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753–757. https://doi.org/10.1038/nature08192
Sivakumaran S, Agakov F, Theodoratou E et al (2011) Abundant pleiotropy in human complex diseases and traits. Am J Hum Genet 89:607–618. https://doi.org/10.1016/j.ajhg.2011.10.004
So H-C, Sham PC (2017) Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits. Bioinforma Oxf Engl 33:886–892. https://doi.org/10.1093/bioinformatics/btw745
Solovieff N, Cotsapas C, Lee PH et al (2013) Pleiotropy in complex traits: challenges and strategies. Nat Rev Genet 14:483–495. https://doi.org/10.1038/nrg3461
Sørensen HJ, Debost J-C, Agerbo E et al (2018) Polygenic risk scores, school achievement, and risk for schizophrenia: a Danish population-based study. Biol Psychiatry. https://doi.org/10.1016/j.biopsych.2018.04.012
Stroup TS, McEvoy JP, Swartz MS et al (2003) The National Institute of Mental Health clinical antipsychotic trials of intervention effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 29:15–31
Sullivan PF, Lin D, Tzeng J-Y et al (2008) Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 13:570–584. https://doi.org/10.1038/mp.2008.25
Vassos E, Di Forti M, Coleman J et al (2016) An examination of polygenic score risk prediction in individuals with first-episode psychosis. Biol Psychiatry 81:470–477. https://doi.org/10.1016/j.biopsych.2016.06.028
Ware JJ, Chen X, Vink J et al (2016) Genome-wide meta-analysis of cotinine levels in cigarette smokers identifies locus at 4q13.2. Sci Rep 6:20092. https://doi.org/10.1038/srep20092
Wray NR, Lee SH, Mehta D et al (2014) Research review: polygenic methods and their application to psychiatric traits. J Child Psychol Psychiatry 55:1068–1087. https://doi.org/10.1111/jcpp.12295